AA
NVAX icon

ALPS Advisors’s Novavax NVAX Stock Holding History

ALPS Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$461K Sell
48,989
-132,036
-73% -$1.18M ﹤0.01% 1011
2026
Q1 		$1.47M Buy
181,025
+47,593
+36% +$431K 0.01% 465
2025
Q4 		$897K Buy
133,432
+57,675
+76% +$435K 0.01% 584
2025
Q3 		$657K Sell
75,757
-11,576
-13% -$90.1K ﹤0.01% 626
2025
Q2 		$550K Sell
87,333
-26,898
-24% -$178K ﹤0.01% 613
2025
Q1 		$732K Sell
114,231
-15,299
-12% -$126K ﹤0.01% 544
2024
Q4 		$1.04M Buy
+129,530
New +$1.25M 0.01% 470
2023
Q2 		– Sell
-56,775
Closed -$393K – 1021
2023
Q1 		$393K Buy
56,775
+3,560
+7% +$32.8K ﹤0.01% 626
2022
Q4 		$547K Buy
53,215
+10,502
+25% +$185K ﹤0.01% 575
2022
Q3 		$777K Sell
42,713
-3,642
-8% -$158K 0.01% 517
2022
Q2 		$2.38M Buy
+46,355
New +$2.4M 0.02% 283

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

ALPS Advisors's NVAX Position: Q2 2026 in Review

ALPS Advisors reduced its Novavax (NVAX) stake by 73% in Q2 2026, selling an estimated $1.18M and leaving 48,989 shares worth $461K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

ALPS Advisors first reported a position in NVAX in Q2 2022 and has held it in 11 quarters since. The position peaked at $2.38M in Q2 2022. 268 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • ALPS Advisors held 48,989 shares of Novavax worth $461K as of Q2 2026.
  • ALPS Advisors sold 132,036 Novavax shares in Q2 2026, an estimated $1.18M.
  • Novavax made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1011 holding.
  • ALPS Advisors first reported a position in Novavax in Q2 2022 and has held it in 11 quarters since.
  • ALPS Advisors's Novavax position peaked at $2.38M in Q2 2022.
  • 268 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.